Scorpius Holdings(SCPX) - 2023 Q4 - Annual Results

Form 8-K Filing Information This section details the registrant's identification, incorporation, SEC file number, and contact information, including its former name Registrant Details This section provides the core identification details for Scorpius Holdings, Inc., including its incorporation state, SEC file number, and primary contact information, noting its former name - Registrant: Scorpius Holdings, Inc. (formerly NightHawk Biosciences, Inc.)[2][3] - Jurisdiction of Incorporation: Delaware[2] - Commission File Number: 001-35994[2] Securities Information Details the classes of securities registered under Section 12(b) of the Act and confirms the registrant's status regarding emerging growth company provisions | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | :------------------------- | :---------------- | :---------------------------------------- | | Common Stock, $0.0002 par value per share | SCPX | NYSE American LLC | | Common Stock Purchase Rights | | NYSE American LLC | - The registrant is not an emerging growth company[4] Item 2.02. Results of Operations and Financial Condition This section reports preliminary unaudited revenue results for Q4 2023 and includes disclaimers regarding their provisional nature Preliminary Unaudited Revenue Results Scorpius Holdings, Inc. announced preliminary unaudited revenue results for the three months ended December 31, 2023, via a press release furnished as Exhibit 99.1 - On March 7, 2024, Scorpius Holdings, Inc. issued a press release announcing preliminary unaudited revenue results for the three months ended December 31, 2023[5] - These results are based upon management estimates[5] - A copy of the press release is furnished as Exhibit 99.1[5] Disclaimer on Preliminary Information The company emphasizes that the reported revenue and operating loss results are preliminary, unaudited, and subject to change, advising against undue reliance due to potential material adjustments and lack of independent audit or review - The estimated revenue and operating loss results for 2023 are preliminary and unaudited, subject to completion of the Company's financial closing procedures[6] - The Company's independent registered public accounting firm has not conducted an audit or review of these preliminary results[6] - Adjustments to the preliminary estimates may be required and could be material, therefore undue reliance should not be placed on these estimates[6] Item 7.01. Regulation FD Disclosure This section outlines upcoming investor presentations and includes important disclaimers regarding forward-looking statements and legal filing status Investor Presentations Scorpius Holdings, Inc. plans to conduct investor presentations over the coming weeks, utilizing an investor presentation furnished as Exhibit 99.2 - The Company will be making several presentations to investors over the next several weeks[8] - The Company intends to discuss the investor presentation furnished as Exhibit 99.2[8] Forward-Looking Statements Disclaimer The company clarifies that the information related to investor presentations is not considered 'filed' for certain legal purposes and includes 'safe harbor' language for forward-looking statements - The information in Item 7.01 and Exhibit 99.2 is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to liabilities of Section 11 and 12(a)(2) of the Securities Act of 1933[9] - The investor presentation includes 'safe harbor' language pursuant to the Private Securities Litigation Reform Act of 1995 for forward-looking statements[10] Item 9.01 Financial Statements and Exhibits This section provides a comprehensive list of all documents filed as exhibits to the Form 8-K, including press releases and investor presentations List of Exhibits This section lists the documents filed as exhibits to the Form 8-K, including a press release, an investor presentation, and the interactive data file | Exhibit Number | Description | | :------------- | :-------------------------------- | | 99.1 | Press release dated March 7, 2024 | | 99.2 | Investor Presentation dated March 7, 2024 | | 104 | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document) | SIGNATURES This section confirms the official signing of the report by the authorized corporate officer of Scorpius Holdings, Inc Signature Details The report was duly signed on behalf of Scorpius Holdings, Inc. by its Chairman, President, and Chief Executive Officer - The report was signed on March 7, 2024[15] - Signed by Jeffrey Wolf, Chairman, President and Chief Executive Officer of Scorpius Holdings, Inc.[15]